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dantly in the cerebellar Purkinje and granule cells  [1] .
CACNA1A mutations are associated with several domi-
nantly inherited disorders with both episodic and pro-
gressive neurological signs and symptoms, namely famil-
ial hemiplegic migraine type 1 (FHM1, MIM#141500)  [2] , 
episodic ataxia type 2 (EA2, MIM#108500)  [2] , spinocer-
ebellar ataxia type 6 (SCA6, MIM#183086)  [3] , general-
ized epilepsy  [4] , and congenital myasthenia  [5] . FHM1 is 
characterized by migraine attacks with ictal hemiplegia 
variably associated with episodic and progressive ataxia. 
EA2 patients experience recurrent episodes of ataxia, 
vertigo, nausea and fluctuating weakness. Both FHM1 
and EA2 patients may have interictal nystagmus and oth-
er moderate cerebellar signs  [6, 7] . SCA6 patients typi-
cally suffer from progressive cerebellar ataxia but may 
also have episodic ataxia  [8] . Initial reports suggested
that FHM1 is caused by missense and EA2 by trunca-
tion (nonsense, frameshift, splice site) mutations in the 
CACNA1A gene, while small CAG-triplet expansions re-
sulted in SCA6  [2, 3, 6] . Subsequent reports, however, 
questioned this strict genotype-phenotype correlation, 
since there is considerable overlap of symptoms among 
the three allelic conditions  [7–10] .
 We herein report on a daughter and her mother with 
the  CACNA1A missense mutation R1668W, first de-
scribed in other families with hemiplegic migraine vari-
ably associated with progressive ataxia, but without epi-
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 Abstract 
 We describe a family with an R1668W mutation in the
CACNA1A gene who presented with a broader clinical spec-
trum and more variable features than previously reported. 
The mother had a pure progressive cerebellar ataxia of late 
onset with downbeat nystagmus, whereas her daughter suf-
fered from episodic ataxia, hemiplegic migraine, and pro-
gressive cerebellar ataxia with horizontal gaze-evoked and 
rebound nystagmus. In both patients, treatment with acet-
azolamide was ineffective and worsened baseline ataxia, 
whereas flunarizine ameliorated episodic symptoms. Our re-
port highlights profound phenotypic variability that can be 
associated with CACNA1A mutations and adds important 
therapeutic considerations.  Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 The CACNA1A gene on chromosome 19p13 encodes 
the pore-forming subunit of the P/Q-type voltage-gated
calcium channel, which is expressed particularly abun-
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sodic symptoms  [6] . Furthermore, our index patient and 
her mother, although harboring the same mutation, are 
differentially affected: The daughter suffered from epi-
sodic ataxia, hemiplegic migraine, and moderate pro-
gressive cerebellar ataxia with onset in her late 20s, 
whereas the mother had isolated severe progressive cer-
ebellar ataxia with onset in her late 40s. Moreover, the 
two family members exhibited different patterns of cer-
ebellar ocular motor deficiencies.
 Case Reports 
 Case 1 
 Over the past 9 years, the 39-year-old woman has experienced 
several episodes of spontaneous acute vertigo, gait ataxia, and 
weakness. Attacks lasted a few minutes and occurred less than 
once a month. The patient described spinning and see-sawing 
sensations during the attacks exacerbated by head movement. 
There were no prodromal symptoms and no other otologic or 
neurologic symptoms during these episodes. Since adolescence, 
the patient had suffered from severe and frequent migraine head-
aches without aura, which decreased markedly in frequency and 
severity after the age of 30 years. In the past 3 years she has had 
two attacks, lasting 10–15 min, with sudden left-sided hemipare-
sis, paresthesia of the left leg, and dysarthria, without associated 
dizziness or headaches. She has noticed slowly progressive un-
steadiness of gait for 2 years. Neurological examination revealed 
a moderate pancerebellar syndrome with prominent ocular mo-
tor signs ( table 1 ). Laboratory testing showed positive serum para-
neoplastic cerebellar antibodies (anti-Ri). Extensive search for 
neoplasia, however, did not reveal any signs of a primary tumor. 
Brain MRI showed mild midline cerebellar atrophy. Treatment 
with acetazolamide up to 750 mg/day for 3 months did not reduce 
the frequency of attacks, and had to be stopped because of con-
tinuous dizziness, increased gait difficulties, and generalized par-
esthesias. Treated with the calcium channel antagonist flunari-
zine 5 mg/day for 9 months, the patient has experienced no more 
attacks of dizziness or hemiplegic migraine, while the unsteadi-
ness of gait at baseline remained stable.
 Case 2 
 The 73-year-old mother reported progressive gait unsteadi-
ness starting at age 48. Over the past 3 years she was unable to 
walk unaided. Increasing clumsiness of the upper limbs and 
slurred speech developed 5 years ago. She never experienced mi-
graine headaches, dizziness or hemiparesis. Neurological exami-
nation revealed a severe pancerebellar syndrome with only mild 
ocular motor abnormalities ( table 1 ). Tendon reflexes were brisk 
and slightly accentuated on the left side. Plantar responses were 
flexor on the right side and extensor on the left side. Routine lab-
oratory testing was normal. Testing for paraneoplastic cerebellar 
antibodies was negative. Cerebral MRI showed marked atrophy 
of cerebellar vermis and some isolated small supratentorial T 2 -
hyperintensities, most probably reflecting chronic vascular le-
sions. Treatment with acetazolamide up to 750 mg for 3 months 
caused the unsteady gait to markedly worsen that the patient fell 
repeatedly. After cessation of acetazolamide, her clinical condi-
tion returned to baseline. Treatment with flunarizine for 9 months 
(5 mg/day) resulted in little change in the patient’s condition.
 Except for the deceased grandmother of our index patient, 
who suffered from gait unsteadiness and dizziness in advanced 
age, none of the mother’s siblings nor the brother of the index pa-
tient suffers from neurological symptoms.
 Ocular Motor Findings 
 Horizontal and vertical eye movements ( fig. 1 ) were 
recorded with magnetic search coils. Details of the search 
coil recordings are listed in the figure legend.
 Molecular Analysis 
 We screened for polymorphisms in CACNA1A using 
denaturing high-performance liquid chromatography 
(dHPLC) followed by direct sequencing, as previously de-
scribed  [5] . Exon 32 showed an altered elution profile by 
dHPLC in the proband and her mother but not in 96 nor-
mal control subjects. Sequencing of exon 32 showed a sin-
gle nucleotide change c 1 t at position 5250 of the coding 
sequence, predicting a change from arginine to trypto-
phan at codon 1668 in the putative S-4 voltage sensor in 
domain IV.
Table 1. Clinical findings at initial assessment and Klockgether 
Ataxia Score at initial assessment and follow-up
Daughter Mother
1 Ocular motor findings
Horizontal gaze-evoked nystagmus ++ –
Horizontal rebound nystagmus + –
Downbeat nystagmus – +
Impaired smooth pursuit eye movements + +
Hypometric saccades + +
Square wave jerks – +
2 Dysarthria – +++
3 Incoordination of upper and lower limbs + +++
4 Ataxia of gait + +++
5 Klockgether Ataxia Score [14]
Initial assessment 03/04 (no treatment) 7/35 15/35
LAST follow-up under therapy with
flunarizine 06/05 4/35 17/35
+ = Mild, ++ = moderate, +++ = severe.
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 Fig. 1.  a Consecutive representative sec-
tions of horizontal eye position (H) at at-
tempted visual fixations 20° to the left 
(first column, ‘left’), straight ahead (sec-
ond column, ‘straight ahead’), 20° to the 
right (third column, ‘right’), and straight 
ahead again (fourth column, ‘straight 
ahead’). Duration of sections: 2.5 s. The 
daughter (DH) showed prominent hori-
zontal gaze-evoked nystagmus with cen-
tripetal ocular drift in eccentric gaze posi-
tions. When the eyes return to straight 
ahead, rebound nystagmus, i.e. nystagmus 
directed opposite of the previous gaze-
evoked nystagmus, was present. The moth-
er (MH) only exhibited minimal centrip-
etal drift in gaze to the right and no re-
bound nystagmus.  b Vertical eye position 
(V) at attempted visual fixations 20° up 
(top row, ‘up’), straight ahead (middle row, 
‘straight ahead’), and 20° down (bottom 
row, ‘down’). Duration of sections: 2.5 s. 
The mother (MV) demonstrated down-
beat nystagmus in gaze straight ahead, 
which increased in downgaze and de-
creased in upgaze. Downbeat nystagmus 
was not present in the daughter (DV). 
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 Discussion 
 We report a family with the CACNA1A missense mu-
tation R1668W. While our index patient had a particular 
phenotype with combined features of hemiplegic mi-
graine, episodic ataxia, and progressive ataxia, her moth-
er suffered from pure progressive cerebellar ataxia with-
out episodic symptoms and without migraine.
 A disease-causing role of the R1668W mutation in our 
patients is very likely, since this mutation has been previ-
ously described in a family with pure hemiplegic mi-
graine and another with hemiplegic migraine and per-
manent cerebellar signs  [6] , and screening for polymor-
phisms in  CACNA1A was negative in 96 control subjects. 
Presumably, the mutation leads to altered channel kine-
matics since it predicts an amino acid exchange in the 
putative S-4 voltage sensor in domain IV of the P/Q-type 
voltage-gated calcium channel.
 Our cases illustrate the broad clinical spectrum and 
variable symptomatology associated with  CACNA1A 
mutations. This is in line with previous reports demon-
strating phenotypic variability of  CACNA1A mutations, 
hampering a simple genotype-phenotype correlation. In-
deed, EA2 phenotypes are associated with nonsense and 
missense mutations as well as CAG-triplet repeat expan-
sions  [6, 7, 9] . On the other hand,  CACNA1A missense 
mutations are also associated with severe progressive cer-
ebellar ataxia with episodic vertigo and ataxia  [10] . Ad-
ditional genetic, for example the number of CAG repeats 
on the normal allele, and/or environmental factors must 
contribute to the phenotypic variability associated with 
distinct  CACNA1A mutations.
 This phenotypic diversity is reflected not only in the 
clinical but also in the ocular motor findings in the two 
affected family members. The index patient showed 
marked horizontal gaze-evoked and rebound nystagmus, 
whereas the mother exhibited square wave jerks and 
spontaneous downbeat nystagmus. We therefore specu-
late that, in the 2 patients, the R1668W mutation differ-
entially alters the function of vestibulo-cerebellar struc-
tures, especially the flocculus. While gaze-evoked and 
rebound nystagmus indicates a failure of gaze-holding 
mechanisms, downbeat nystagmus suggests primarily a 
dysfunction of vertical gaze-velocity sensitive Purkinje 
cells  [11] .
 The finding of elevated anti-Ri antibodies in the index 
patient may be suspicious for paraneoplastic cerebellar 
degeneration, yet the patient did not manifest opsoclo-
nus, myoclonus, or dystonia, symptoms which are often 
associated with anti-Ri antibodies  [12] . Furthermore, the 
temporal progression of her symptoms is far less pro-
nounced than what is typically found in paraneoplastic 
cerebellar degeneration, and extensive tumor screening 
in the patient has remained negative. Whether the anti-Ri 
antibodies in our index patient play a primary pathogen-
ic role, or whether they are a secondary phenomenon 
caused by an unusual epitope presentation in the context 
of a neurodegenerative process, remains unresolved. 
Also, we can only speculate whether the presence of anti-
Ri antibodies, at least in part, may have contributed to the 
phenotypic diversity between mother and daughter.
 This report also raises important therapeutic consid-
erations. Therapeutic interventions in other families har-
boring the R1668W mutation have not been described  [6] . 
In our index patient and her mother, treatment with ac-
etazolamide was ineffective for the episodic neurological 
symptoms and even exacerbated baseline cerebellar 
symptoms. By contrast, the calcium channel antagonist 
flunarizine was effective in controlling episodic symp-
toms without worsening of progressive symptoms. Suc-
cessful treatment with flunarizine was previously de-
scribed in a boy suffering from periodic ataxia without 
any sign of progressive cerebellar disease; however, this 
report appeared before the genetic characterization of 
EA2, and whether this boy had a mutation in  CACNA1A 
cannot be determined  [13] . Our experience with the in-
dex patient in this report compels us to propose that flu-
narizine be considered in EA patients who do not respond 
to acetazolamide. A different effect of the drugs on spe-
cific channel kinematics seems likely.
 In conclusion, we confirm that  CACNA1A mutations 
are associated with considerable phenotypic variability, 
even within family members harboring the same muta-
tion. Further studies will be necessary to elucidate the 
basis of this phenotypic variability of  CACNA1A muta-
tions.
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